Correlation Between ZyVersa Therapeutics and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on ZyVersa Therapeutics and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Sonnet Biotherapeutics.
Diversification Opportunities for ZyVersa Therapeutics and Sonnet Biotherapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ZyVersa and Sonnet is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Sonnet Biotherapeutics
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Sonnet Biotherapeutics. In addition to that, ZyVersa Therapeutics is 1.46 times more volatile than Sonnet Biotherapeutics Holdings. It trades about -0.09 of its total potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.05 per unit of volatility. If you would invest 1,112 in Sonnet Biotherapeutics Holdings on August 26, 2024 and sell it today you would lose (814.00) from holding Sonnet Biotherapeutics Holdings or give up 73.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Sonnet Biotherapeutics |
ZyVersa Therapeutics and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Sonnet Biotherapeutics
The main advantage of trading using opposite ZyVersa Therapeutics and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Sonnet Biotherapeutics vs. Eliem Therapeutics | Sonnet Biotherapeutics vs. HCW Biologics | Sonnet Biotherapeutics vs. Scpharmaceuticals | Sonnet Biotherapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |